These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 10867652
1. Lysosomal accumulation of drugs in drug-sensitive MES-SA but not multidrug-resistant MES-SA/Dx5 uterine sarcoma cells. Wang E, Lee MD, Dunn KW. J Cell Physiol; 2000 Aug; 184(2):263-74. PubMed ID: 10867652 [Abstract] [Full Text] [Related]
2. Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA scission. Harker WG, Bauer D, Etiz BB, Newman RA, Sikic BI. Cancer Res; 1986 May; 46(5):2369-73. PubMed ID: 3754487 [Abstract] [Full Text] [Related]
3. Human sarcoma cell lines MES-SA and MES-SA/Dx5 as a model for multidrug resistance modulators screening. Wesolowska O, Paprocka M, Kozlak J, Motohashi N, Dus D, Michalak K. Anticancer Res; 2005 May; 25(1A):383-9. PubMed ID: 15816562 [Abstract] [Full Text] [Related]
4. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells. Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH. Life Sci; 2008 Nov 21; 83(21-22):700-8. PubMed ID: 18845169 [Abstract] [Full Text] [Related]
5. Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin- resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy. Angelini A, Di Ilio C, Castellani ML, Conti P, Cuccurullo F. J Biol Regul Homeost Agents; 2010 Nov 21; 24(2):197-205. PubMed ID: 20487633 [Abstract] [Full Text] [Related]
6. Anticancer effects of a specific mixture of nutrients in the multidrug-resistant human uterine sarcoma MES-SA/Dx5 and the drug-sensitive MES-SA cell lines. Roomi MW, Kalinovsky T, Roomi NW, Rath M, Niedzwiecki A. Oncol Rep; 2012 Jan 21; 27(1):17-27. PubMed ID: 21947138 [Abstract] [Full Text] [Related]
7. The acridonecarboxamide GF120918 potently reverses P-glycoprotein-mediated resistance in human sarcoma MES-Dx5 cells. Traunecker HC, Stevens MC, Kerr DJ, Ferry DR. Br J Cancer; 1999 Nov 21; 81(6):942-51. PubMed ID: 10576649 [Abstract] [Full Text] [Related]
8. Monitoring incorporation, transformation and subcellular distribution of N-l-leucyl-doxorubicin in uterine sarcoma cells using capillary electrophoretic techniques. Wang Y, Arriaga EA. Cancer Lett; 2008 Apr 08; 262(1):123-32. PubMed ID: 18194838 [Abstract] [Full Text] [Related]
9. Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA. Harker WG, Sikic BI. Cancer Res; 1985 Sep 08; 45(9):4091-6. PubMed ID: 4028002 [Abstract] [Full Text] [Related]
10. The effect of the plasticizer diethylhexyl phthalate on transport activity and expression of P-glycoprotein in parental and doxo-resistant human sarcoma cell lines. Angelini A, Centurione L, Sancilio S, Castellani ML, Conti P, Di Ilio C, Porreca E, Cuccurullo F, Di Pietro R. J Biol Regul Homeost Agents; 2011 Sep 08; 25(2):203-11. PubMed ID: 21880209 [Abstract] [Full Text] [Related]
11. Hexane fraction of adlay (Coix lachryma-jobi L.) testa ethanolic extract inhibits human uterine sarcoma cancer cells growth and chemosensitizes human uterine sarcoma cells to doxorubicin. Chang CC, Huang LH, Chiang W, Hsia SM. Phytomedicine; 2018 Aug 01; 47():69-80. PubMed ID: 30166110 [Abstract] [Full Text] [Related]
12. Reversal of P-glycoprotein-mediated multidrug resistance in human sarcoma MES-SA/Dx-5 cells by nonsteroidal anti-inflammatory drugs. Angelini A, Iezzi M, Di Febbo C, Di Ilio C, Cuccurullo F, Porreca E. Oncol Rep; 2008 Oct 01; 20(4):731-5. PubMed ID: 18813811 [Abstract] [Full Text] [Related]
13. Reversal of doxorubicin, etoposide, vinblastine, and taxol resistance in multidrug resistant human sarcoma cells by a polymer of spermine. Gosland MP, Gillespie MN, Tsuboi CP, Tofiq S, Olson JW, Crooks PA, Aziz SM. Cancer Chemother Pharmacol; 1996 Oct 01; 37(6):593-600. PubMed ID: 8612315 [Abstract] [Full Text] [Related]
14. Inhibition of P-glycoprotein-mediated transport by S-adenosylmethionine and cynarin in multidrug-resistant human uterine sarcoma MES-SA/Dx5 cells. Angelini A, Di Pietro R, Centurione L, Castellani ML, Conti P, Porreca E, Cuccurullo F. J Biol Regul Homeost Agents; 2012 Oct 01; 26(3):495-504. PubMed ID: 23034269 [Abstract] [Full Text] [Related]
15. Stable suppression of MDR-1 gene using siRNA expression vector to reverse drug resistance in a human uterine sarcoma cell line. Hua J, Mutch DG, Herzog TJ. Gynecol Oncol; 2005 Jul 01; 98(1):31-8. PubMed ID: 15921732 [Abstract] [Full Text] [Related]
16. [The in vitro cytotoxicity and in vivo toxicity of doxorubicin antiresistant stealth liposomes]. Wang JC, Liu XY, Lü WL, Lee HS, Goh BC, Zhang Q. Yao Xue Xue Bao; 2005 May 01; 40(5):475-80. PubMed ID: 16220797 [Abstract] [Full Text] [Related]
17. Different effects of magnetic field on drug activity in human uterine sarcoma cell lines MES-SA and MES-SA/Dx5. Shibaki R, Kakikawa M. Electromagn Biol Med; 2022 Jul 03; 41(3):343-351. PubMed ID: 35793396 [Abstract] [Full Text] [Related]
18. FZD1 activates protein kinase C delta-mediated drug-resistance in multidrug-resistant MES-SA/Dx5 cancer cells. Hung TH, Chen CM, Tseng CP, Shen CJ, Wang HL, Choo KB, Chong KY. Int J Biochem Cell Biol; 2014 Aug 03; 53():55-65. PubMed ID: 24814288 [Abstract] [Full Text] [Related]
19. Antiproliferative effect of pheophorbide a-mediated photodynamic therapy and its synergistic effect with doxorubicin on multiple drug-resistant uterine sarcoma cell MES-SA/Dx5. Cheung KK, Chan JY, Fung KP. Drug Chem Toxicol; 2013 Oct 03; 36(4):474-83. PubMed ID: 23560455 [Abstract] [Full Text] [Related]
20. Reversal by cefoperazone of resistance to etoposide, doxorubicin, and vinblastine in multidrug resistant human sarcoma cells. Gosland MP, Lum BL, Sikic BI. Cancer Res; 1989 Dec 15; 49(24 Pt 1):6901-5. PubMed ID: 2582432 [Abstract] [Full Text] [Related] Page: [Next] [New Search]